neratinib
puma,pierre fabre,knight therapeutics
['neratinib', 'tnbc']
top cited study shares final results of #neratinib in her2+/hr+ #ebc from #extenet trial co-author sibylle loibl will present on #immunotherapy for patients with early-stage #tnbc at #asco22 on june 7 @ 8 am ct 
Latest research and news from Elsevier Oncology journals. Publishing support: https://t.co/0zIQ5ZFYVL